By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Has a Good Idea; Doctors Object
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > FDA Has a Good Idea; Doctors Object
BusinessNewsPublic Health

FDA Has a Good Idea; Doctors Object

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

The idea: In a move that could help the government trim its burgeoning health care costs, the Food and Drug Administration may soon permit Americans to obtain some drugs used to treat conditions such as high blood pressure and diabetes without obtaining a prescription.

The idea: In a move that could help the government trim its burgeoning health care costs, the Food and Drug Administration may soon permit Americans to obtain some drugs used to treat conditions such as high blood pressure and diabetes without obtaining a prescription.

The Doctors’ Objection: “What the government via the FDA has decided to do is just bypass the expensive doctor and to satisfy some safety concerns of letting people just pick out their medications is make sure they have to get counsel by the pharmacists,” Dr. Mintz [an internist at George Washington University Hospital] said. “I believe there is value to using pharmacists, but not at the expense of primary care.”

The Pharmacists Counter: “We think it’s a great development for everybody — for pharmacists, for patients and the whole health care system,” said Brian Gallagher, a lobbyist for the American Pharmacists Association. “The way we look at it is there are a lot of people out there with chronic conditions that are undertreated and this would enable the pharmacists to redirect these undertreated people back into the health care system.”

More Read

Pfizer and Hospira: It’s Not About Generics
People with Disabilities Can Access SIL Funding with the NDIS
The Second Wave of Healthcare Informatics
Disruptions on the Yellow Brick Road
Rising Health Costs Affect Us All

More from Paige Winfield Cunningham in the Washington Times.

  

TAGGED:FDApharmaceuticals
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

health care workers working together
How an MBA Healthcare Management Online Program Equips Leaders for Tomorrow
Health
March 18, 2026
close up of hands holding baby feet
What to Record After a Preventable Birth Injury
Health care
March 14, 2026
Person Stressed Out in Courtroom
How Legal Challenges Can Affect Health and Wellness Journeys
Policy & Law
March 14, 2026
high-risk mdical case
Countdown To Care: What Happens In The 48 Hours Before A High-Risk Medical Case
Health Infographics
March 12, 2026

You Might also Like

Report: Childrens Healthcare Spending Outpacing Adults

July 6, 2012
dollarshc
BusinessFinanceHospital AdministrationPolicy & LawPublic Health

Sky-High Hospital Prices: A Result of Government Interference

December 17, 2013
Bo
BusinessHealth ReformHospital AdministrationPolicy & LawPublic Health

Healthcare Is Part of Our Supply Chain: The Boeing Company

December 9, 2014
eHealthHospital AdministrationNewsPolicy & LawTechnology

Cost of Non-Compliance with HIPAA and HITECH

October 11, 2017
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?